An anti-inflammatory diet as treatment for inflammatory bowel disease: A case series report

Nutrition Journal

Volumn 13, Issue 1, 2014, Pages

  Olendzki, Barbara C ^a   Silverstein, Taryn D ^b   Persuitte, Gioia M ^a   Ma, Yunsheng ^a   Baldwin, Katherine R ^b   Cave, David ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Diet; Inflammatory bowel disease; Nutrition

Indexed keywords

ADULT; AGED; ANTIINFLAMMATORY DIET; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DEFECATION HABIT; DIET THERAPY; FEMALE; FOLLOW UP; HARVEY BRADSHAW INDEX; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MODIFIED TRUELOVE AND WITTS SEVERITY INDEX; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT RESPONSE; VERY ELDERLY; YOUNG ADULT; DIETARY FIBER; INTESTINE; MICROBIOLOGY; SELF REPORT;

ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DIETARY FIBER; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MIDDLE AGED; PATIENT COMPLIANCE; PROBIOTICS; RETROSPECTIVE STUDIES; SELF REPORT;

EID: 84893695347     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-13-5     Document Type: Article

References (47)

1. Crohn's and colitis in children and adolescents. Day AS, Ledder O, Leach ST, Lemberg DA, World J Gastroenterol 2012 18 5862 5869 10.3748/wjg.v18.i41.5862 23139601
2. Existing dietary guidelines for Crohn's disease and ulcerative colitis. Brown AC, Rampertab SD, Mullin GE, Expert Rev Gastroenterol Hepatol 2011 5 411 425 10.1586/egh.11.29 21651358
3. Balfour Sartor R, Probiotics for Gastrointestinal Diseases UpToDate 2013.Location: 95 Sawyer Rd. Waltham, MA UpToDate 2013. 2013 02453
4. Fecal Microbiota Tranplantation. Bl AO, Curr Opin Gastroenterol 2013 29 1 79 84 10.1097/MOG.0b013e32835a4b3e 23041678
5. Recent trends in the surgical management of inflammatory bowel disease. Roses RE, Rombeau JL, World J Gastroenterol 2008 14 408 412 10.3748/wjg.14.408 18200663
6. Ileal pouch-anal anastomoses complications and function in 1005 patients. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK, Ann Surg 1995 222 120 127 10.1097/00000658-199508000-00003 7639579
7. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR, Br J Surg 2007 94 333 340 10.1002/bjs.5464 17225210
8. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Bassi A, Dodd S, Williamson P, Bodger K, Gut 2004 53 1471 1478 10.1136/gut.2004.041616 15361497
9. Guidelines for the management of inflammatory bowel disease in adults. Carter MJ, Lobo AJ, Travis SP, IBD Section, British Society of Gastroenterology, Gut 2004 53 Suppl 5 &221 V16 15306569
10. Nutrition and diet in inflammatory bowel disease. Yamamoto T, Curr Opin Gastroenterol 2013 29 216 221 10.1097/MOG.0b013e32835b9a40 23385526
11. Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Triggs CM, Munday K, Hu R, Fraser AG, Gearry RB, Barclay ML, Ferguson LR, Mutat Res 2010 690 123 138 10.1016/j.mrfmmm.2010.01.020 20144628
12. Food intolerance and Crohn's disease. Pearson M, Teahon K, Levi AJ, Bjarnason I, Gut 1993 34 783 787 10.1136/gut.34.6.783 8314511
13. Haas SV, Haas MP, Management of celiac disease Lippincott, Philadelphia 1951
14. Designing and developing a literature-derived, population-based dietary inflammatory index. Shivappa N, Steck SE, Hurley TG, Hussey JR, Hebert JR, Public Health Nutr 2013 14 1 8
15. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene IS, Hebert JR, J Nutr 2009 139 2365 2372 10.3945/jn.109.114025 19864399
16. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S, N Engl J Med 1994 330 1841 1845 10.1056/NEJM199406303302601 8196726
17. Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. Vermeire S, Schreiber S, Sandborn WJ, Dubois C, Rutgeerts P, Clin Gastroenterol Hepatol 2010 8 357 363 10.1016/j.cgh.2010.01.001 20096379
18. Dysbiosis in inflammatory bowel disease. Tamboli CP, Neut C, Desreumaux P, Colombel JF, Gut 2004 53 1 4 10.1136/gut.53.1.1 14684564
19. How can probiotics and prebiotics impact mucosal immunity? O'Flaherty S, Saulnier DM, Pot B, Versalovic J, Gut Microbes 2010 1 293 300 10.4161/gmic.1.5.12924 21327037
20. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Fujimori S, Gudis K, Mitsui K, Seo T, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C, Nutrition (Burbank, Los Angeles County, Calif 2009 25 520 525 10.1016/j.nut.2008.11.017
21. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. Bosscher D, Breynaert A, Pieters L, Hermans N, J Physiol Pharmacol 2009 60 Suppl 6 5 11
22. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Hunter JO, Cole JA, FEMS microbiology letters 2010 310 138 144 10.1111/j.1574-6968.2010.02057.x 20695899
23. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. McFarland LV, World J Gastroenterol 2010 16 18 2202 2222 10.3748/wjg.v16.i18.2202 20458757
24. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA, Macfarlane GT, Gut 2005 54 242 249 10.1136/gut.2004.044834 15647189
25. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G, Clin Exp Immunol 2007 149 470 479 10.1111/j.1365-2249.2007.03434.x 17590176
26. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Hou JK, Abraham B, El-Serag H, Am J Gastroenterol 2011 106 563 573 10.1038/ajg.2011.44 21468064
27. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease. Guerreiro CS, Ferreira P, Tavares L, Santos PM, Neves M, Brito M, Cravo M, Am J Gastroenterol 2009 104 2241 2249 10.1038/ajg.2009.313 19550417
28. Current and emerging drugs for the treatment of inflammatory bowel disease. Triantafillidis JK, Merikas E, Georgopoulos F, Drug Des Devel Ther 2011 5 185 210 21552489
29. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Wall R, Ross RP, Fitzgerald GF, Stanton C, Nutrition reviews 2010 68 280 289 10.1111/j.1753-4887.2010.00287.x 20500789
30. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marin-Jimenez I, Arriaza E, Olleros T, Delgado M, Castillejo MS, Prieto-Merino D, Gonzalez Lara V, Pena AS, World J Gastroenterol 2008 14 2851 2857 10.3748/wjg.14.2851 18473409
31. Psychosocial predictors of four health-promoting behaviors for cancer prevention using the stage of change of Transtheoretical Model. Choi JH, Chung KM, Park K, Psycho-Oncology 2013 29 22 2253 2261
32. The future of IBD treatment. Podolsky DK, J Gastroenterol 2003 38 Suppl 15 63 66 12698875
33. Probiotic effects on inflammatory bowel disease. Sheil B, Shanahan F, O'Mahony L, J Nutr 2007 137 819S 824S 17311981
34. Microbiota in pediatric inflammatory bowel disease. Schwiertz A, Jacobi M, Frick JS, Richter M, Rusch K, Kohler H, J Pediatr 2010 157 240 244.e1 10.1016/j.jpeds.2010.02.046 20400104
35. Galland L, Rakel: Integrative Medicine Philadelphia: Saunders Elsevier 2 2007
36. Influence of dietary blueberry and broccoli on cecal microbiota activity and colon morphology in mdr1a(-/-) mice, a model of inflammatory bowel diseases. Paturi G, Mandimika T, Butts CA, Zhu S, Roy NC, McNabb WC, Ansell J, Nutrition 2012 28 3 324 330 10.1016/j.nut.2011.07.018 22113065
37. Mucosal healing in inflammatory bowel disease. Osterman M, J Clin Gastroenterol 2013 47 3 212 221 10.1097/MCG.0b013e3182732ff5 23340060
38. Nutritional deficiencies in inflammatory bowel disease: Therapeutic approaches. Massironi S, Rossi R, Cavalcoli F, Della Valle S, Fraquell IM, Conte D, Clin Nutr 2013 S0261-5614 13 00098 8
39. Nutritional management of Crohn's disease. Donnellan C, Yann L, Lal S, Therap Adv Gastroenterol 2013 6 3 231 242 10.1177/1756283X13477715 23634187
40. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr, Gastroenterology 2010 139 1147 1155 10.1053/j.gastro.2010.06.070 20637205
41. The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases. Haas SV, Haas MP, Am J Gastroenterol 1955 23 344 360 14361377
42. Gottschall E, Breaking the Vicious Cycle: Intestinal Health through Diet Baltimore, Ontario: Kirkton Press Ltd 2004
43. Prebiotics: the concept revisited. Roberfroid M, J Nutr 2007 137 830S 837S 17311983
44. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Comino I, Real A, de Lorenzo L, Cornell H, Lopez-Casado MA, Barro F, Lorite P, Torres MI, Cebolla A, Sousa C, Gut 2011 60 915 922 10.1136/gut.2010.225268 21317420
45. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Hardy H, Harris J, Lyon E, Beal J, Foey AD, Nutrients 2013 5 1869 1912 10.3390/nu5061869 23760057
46. Diet and intestinal immunity. Tilg H, N Engl J Med 2012 366 181 183 10.1056/NEJMcibr1113158 22236230
47. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Cohen AB, Lee D, Long MD, Kappelman MD, Martin CF, Sandler RS, Lewis JD, Dig Dis Sci 2013 58 1322 1328 10.1007/s10620-012-2373-3 22923336